AR and urinary bladder carcinoma: Several animal studies have shown that androgen and androgen receptor (AR) signaling promotes whereas estrogen inhibits bladder cancer development induced by N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) [10–12].